Results 41 to 50 of about 84 (78)

[Progress and prospects of clinical cell therapy for liver cirrhosis and liver cancer]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2019
Liu K, Wang LF, Wang FS, Shi M.
europepmc   +1 more source

[Biological characteristics and antitumor activity of CIK cells activated by recombinant human fibronectin for human lung cancer cell lines in vitro]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi, 2010
Wang S   +9 more
europepmc   +1 more source

[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2020
Department of Medical Administration   +1 more
europepmc   +1 more source

[Antitumor Study of Neoantigen-reactive T Cells Co-expressing IL-7 and CCL19 
in Mouse Lung Cancer]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi
Wu D   +7 more
europepmc   +1 more source

[Mechanism of NKG2D ligands-mediated immune escape of adriamycin resistant leukemia K562/A02 cells]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2018
Jia ZX   +8 more
europepmc   +1 more source

[Advances in application of adoptive T-cell therapy for cancer patients]. [PDF]

open access: yesZhejiang Da Xue Xue Bao Yi Xue Ban, 2017
Jixia Z, Chengyan Z, Pingli W.
europepmc   +1 more source

[Efficacy and peripheral immunity analysis of allogeneic natural killer cells therapy in patients with hepatocellular carcinoma]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2019
Xie YB   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy